Product Information
TESTOSTERONE CYP 2,000 MG/10 ML is a generic product labeled by Alvogen Inc., priced at $2.3108 per ML under NDC 47781091091. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jun 16, 2017. Its Orange Book therapeutic-equivalence code is AO.
Strength
200 mg/mL
Manufacturer
Alvogen Inc.NDC
47781091091
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
TESTOSTERONE CYPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA207742FDA Approved
6/16/2017
TE Code
AO
On Market Since
11/2/2022
Pharmacological Classes
Price Statistics
The NADAC for TESTOSTERONE CYP 2,000 MG/10 ML has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 17.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3108 per ML |
|---|---|
| All-time high | $2.7090 (Sep 10, 2025) |
| All-time low | $1.8702 (Apr 22, 2026) |
| 52-week high | $2.3108 |
| 52-week low | $1.8702 |
| Median price | $2.1168 |
| Average price | $2.2506 |
| Largest weekly change | -21.9% (Sep 17, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alvogen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
testosterone cypionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TESTOSTERONE CYP 2,000 MG/10 ML?
The current National Average Drug Acquisition Cost (NADAC) for TESTOSTERONE CYP 2,000 MG/10 ML, manufactured by Alvogen Inc., is $2.3108 per ML (NDC 47781091091), effective Sep 30, 2026.
How has the price of TESTOSTERONE CYP 2,000 MG/10 ML changed over time?
Over the history we have for it, the NADAC for TESTOSTERONE CYP 2,000 MG/10 ML has risen 17.0%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for TESTOSTERONE CYP 2,000 MG/10 ML?
Since Apr 17, 2024, the NADAC for TESTOSTERONE CYP 2,000 MG/10 ML has ranged from a low of $1.8702 (Apr 22, 2026) to a high of $2.7090 (Sep 10, 2025), with a median of $2.1168 per ML.
Are there cheaper alternatives to TESTOSTERONE CYP 2,000 MG/10 ML?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TESTOSTERONE CYP 2,000 MG/10 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures TESTOSTERONE CYP 2,000 MG/10 ML?
TESTOSTERONE CYP 2,000 MG/10 ML (NDC 47781091091) is labeled by Alvogen Inc., and CMS classifies it as a generic product.